Description: Accelerated Underwriting – Two Studies (Delphi and SOA Survey)

Description: US pharmacy prices have entered a new era of growth driven by Specialty medications. A bevy of state and national regulations have been proposed to address pharmacy pricing, industry structure and transparency.Health actuaries will learn about US pharmacy pricing structure and how proposed legislation could affect future costs. Actuaries that have responsibility for pharmacy rate/budget setting, RFPs or trend projection will benefit from a deeper understanding of the US pharmacy market landscape and gain an international perspective.

Description: Milliman Risk Score will now consider an applicant's Rx and Credit Data. RGA has developed a comprehensive DHD platform and scoring algorithm to transform raw DHD into actionable underwriting assessments. Both new tools will be presented.

Description: The presenters will describe how the new IFRS 17 requirements will impact the profitability of ULSG products. This could have a significant impact for companies who will be reporting financials based on IFRS 17. The shift from US GAAP to IFRS 17 will likely increase the volatility in IFRS earnings, which may prompt companies to explore potential product changes.

Description: Life insurers in the worksite market face some unique challenges. This session will discuss the valuation findings from a 2019 survey of worksite life companies. Topics will include: Implementation of VM-20 and 2017 CSO Reserving of combination life and health riders, such as chronic or critical illness riders

Description: Learn the fundamentals, promises and myths of blockchain technology; why it's important and relevant today, and how it's evolving our relationships with data, analytics and the science of product development and maintenance. Discuss examples and details with Susan Joseph, and Truman Esmond, VP Solutions and Partnerships for AAIS and Technical Lead for openIDL, AAIS's blockchain network for regulatory reporting.

Description: Employers who purchase disability insurance are increasingly interested in obtaining assistance with broader absence management services. At the same time, paid family leave is gaining in popularity both as a government-mandated benefit and in the context of private insurance plans. The speakers in this session review recent developments in the full spectrum of leave programs, including plan design, pricing and administration.

Description: Since the issuance of IFRS 17 in 2017, the global insurance accounting standard, insurers across the globe have been making huge investment in assessing the impact and implementing the new standard. In late 2018, FASB issued ASU 2018-12 that revises key elements of the U.S. GAAP measurement models and disclosure requirements for long-duration contracts issued by insurers (also called FASB Targeted Improvements). Both standards are becoming effective 1/1/2021 (though IFRS 17 may potentially be deferred by a year). U.S. insurers that have international parents or subsidiaries, and report under a multi-GAAP environment will likely have to adopt both standards. By now most insurers should have nearly completed impact assessment for IFRS 17, designed road map for or have started the implementation journey. With the new U.S. GAAP requirements becoming effective concurrently, it is important to embark on the implementation journey with both standards in mind, and maximize the synergy to achieve cost-saving and design efficiency. This session will briefly introduce the two standards with a conceptual comparison, along with a discussion on where efficiency and synergy can be achieved in a concurrent implementation.

Description: A session detailing how to calculate, understand and explain reserve movements in a PBR world. The session will illustrate how to: Calculate expected and actual reserve movements Analyze the results (SOE/GBS/EBS)Explain the results to a range of audience members, including a non-actuarial focus At the conclusion of the session, attendees will be able to evaluate reserve calculation, explain reserve movements and explain PBR earnings.

Description: Intended for actuaries interested in understanding more about the Medical Loss Ratio and the impact Quality Improving Activities (QIA) and fraud reduction expenses have on the rebate calculation. This session will focus on what expenses qualifies as QIA, examples of programs from major carriers, current regulations and the differences between commercial, and Medicare, and Medicaid requirements.